358 related articles for article (PubMed ID: 1360898)
1. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
[TBL] [Abstract][Full Text] [Related]
3. Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127----Asp, Arg158----Cys) variant.
Feussner G; Ziegler R
Clin Investig; 1992 Jul; 70(7):614-7. PubMed ID: 1392432
[TBL] [Abstract][Full Text] [Related]
4. Identification, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia.
Miller DB; Hegele RA; Wolfe BM; Huff MW
J Clin Endocrinol Metab; 1995 Mar; 80(3):807-13. PubMed ID: 7883834
[TBL] [Abstract][Full Text] [Related]
5. Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.
Sakuma N; Hibino T; Saeki T; Nagata T; Sato T; Okuda N; Matsunaga A; Sasaki J
J Atheroscler Thromb; 2014; 21(9):983-8. PubMed ID: 24953047
[TBL] [Abstract][Full Text] [Related]
6. A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia.
Feussner G; Dobmeyer J; Gröne HJ; Lohmer S; Wohlfeil S
Am J Hum Genet; 1996 Feb; 58(2):281-91. PubMed ID: 8571954
[TBL] [Abstract][Full Text] [Related]
7. Apo E variants in patients with type III hyperlipoproteinemia.
Civeira F; Pocoví M; Cenarro A; Casao E; Vilella E; Joven J; González J; Garcia-Otín AL; Ordovás JM
Atherosclerosis; 1996 Dec; 127(2):273-82. PubMed ID: 9125318
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygote for both rare apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) and E3(Cys112-->Arg, Arg251-->Gly) alleles in a multigeneration pedigree with hyperlipoproteinaemia.
Richard P; Beucler I; Pascual De Zulueta M; Biteau N; De Gennes JL; Iron A
Clin Sci (Lond); 1997 Jul; 93(1):89-95. PubMed ID: 9279208
[TBL] [Abstract][Full Text] [Related]
9. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.
Hopkins PN; Wu LL; Schumacher MC; Emi M; Hegele RM; Hunt SC; Lalouel JM; Williams RR
Arterioscler Thromb; 1991; 11(5):1137-46. PubMed ID: 1680391
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
[TBL] [Abstract][Full Text] [Related]
11. Heterozygosity for apolipoprotein E-4Philadelphia(Glu13----Lys, Arg145----Cys) is associated with incomplete dominance of type III hyperlipoproteinemia.
Lohse P; Rader DJ; Brewer HB
J Biol Chem; 1992 Jul; 267(19):13642-6. PubMed ID: 1352296
[TBL] [Abstract][Full Text] [Related]
12. Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.
Walden CC; Huff MW; Leiter LA; Connelly PW; Hegele RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):699-704. PubMed ID: 7907341
[TBL] [Abstract][Full Text] [Related]
13. Discovery and consequences of apolipoprotein-epsilon(3Groningen): a G-insertion in codon 95/96 that is predicted to cause a premature stop codon.
Dijck-Brouwer DA; van Doormaal JJ; Kema IP; Brugman AM; Kingma AW; Muskiet FA
Ann Clin Biochem; 2005 Jul; 42(Pt 4):264-8. PubMed ID: 15989726
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.
Moriyama K; Sasaki J; Matsunaga A; Arakawa F; Takada Y; Araki K; Kaneko S; Arakawa K
Biochim Biophys Acta; 1992 Sep; 1128(1):58-64. PubMed ID: 1356443
[TBL] [Abstract][Full Text] [Related]
15. A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.
Weisgraber KH; Rall SC; Innerarity TL; Mahley RW; Kuusi T; Ehnholm C
J Clin Invest; 1984 Apr; 73(4):1024-33. PubMed ID: 6323533
[TBL] [Abstract][Full Text] [Related]
16. Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1).
Steinmetz A; Assefbarkhi N; Eltze C; Ehlenz K; Funke H; Pies A; Assmann G; Kaffarnik H
J Lipid Res; 1990 Jun; 31(6):1005-13. PubMed ID: 1973700
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
Mann WA; Gregg RE; Sprecher DL; Brewer HB
Biochim Biophys Acta; 1989 Oct; 1005(3):239-44. PubMed ID: 2804053
[TBL] [Abstract][Full Text] [Related]
18. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
Lin HP; Kao JT
Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new apolipoprotein E variant (E2 Arg142-->Leu) in type III hyperlipidemia.
Richard P; de Zulueta MP; Beucler I; De Gennes JL; Cassaigne A; Iron A
Atherosclerosis; 1995 Jan; 112(1):19-28. PubMed ID: 7772063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
